A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer

Conditions:   Resectable Pancreatic Ductal Adenocarcinoma;   Stage 0 Pancreatic Cancer AJCC v8;   Stage I Pancreatic Cancer AJCC v8;   Stage IA Pancreatic Cancer AJCC v8;   Stage IB Pancreatic Cancer AJCC v8;   Stage II Pancreatic Cancer AJCC v8;   Stage IIA Pancreatic Can cer AJCC v8;   Stage IIB Pancreatic Cancer AJCC v8 Intervention:   Drug: Pyrvinium Pamoate Sponsor:   Thomas Jefferson University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials